|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/11 |
| (11) | Number of the document | 2225376 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08857617.8 |
| Date of filing the European patent application | 2008-11-26 | |
| (97) | Date of publication of the European application | 2010-09-08 |
| (45) | Date of publication and mention of the grant of the patent | 2014-01-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/DK2008/000418 |
| Date | 2008-11-26 |
| (87) | Number | WO 2009/071082 |
| Date | 2009-06-11 |
| (30) | Number | Date | Country code |
| 992050 P | 2007-12-03 | US |
| (72) |
HEDT JÅRN, Maj, DK
|
| (73) |
Santaris Pharma A/S,
Fremtidsvej 3, 2970 H rsholm,
DK
|
| (54) | RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF PIK3CA EXPRESSION |
| RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF PIK3CA EXPRESSION |